1. Home
  2. NXL vs SNES Comparison

NXL vs SNES Comparison

Compare NXL & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$4.82

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Logo SenesTech Inc.

SNES

SenesTech Inc.

HOLD

Current Price

$0.86

Market Cap

6.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXL
SNES
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
6.6M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
NXL
SNES
Price
$4.82
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
116.6K
47.1K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
39.76
77.99
EPS
N/A
N/A
Revenue
$301,647.00
$600,000.00
Revenue This Year
$15.52
$29.00
Revenue Next Year
$100.00
$95.04
P/E Ratio
N/A
N/A
Revenue Growth
78.78
132.56
52 Week Low
$0.22
$0.84
52 Week High
$7.69
$5.13

Technical Indicators

Market Signals
Indicator
NXL
SNES
Relative Strength Index (RSI) 70.21 25.39
Support Level $0.41 N/A
Resistance Level $7.69 $1.78
Average True Range (ATR) 0.48 0.07
MACD 0.30 -0.02
Stochastic Oscillator 65.06 11.34

Price Performance

Historical Comparison
NXL
SNES

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

Share on Social Networks: